Lipidor Ab (LIPI) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.130x

Based on the latest financial reports, Lipidor Ab (LIPI) has a cash flow conversion efficiency ratio of -0.130x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.11 Million ≈ $-227.39K USD) by net assets (Skr16.29 Million ≈ $1.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LIPI market cap overview for the company's overall valuation and market capitalisation.

Lipidor Ab - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Lipidor Ab's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lipidor Ab Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lipidor Ab ranked by their cash flow conversion efficiency. Explore earnings quality score of Lipidor Ab to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
PERFORMANCE SHIPP.
F:DS2
0.030x
Caravelle International Group
NASDAQ:HTCO
0.505x
Tai Twun Enterprise Co Ltd
TW:3432
-0.099x
Catenon S.A
MC:COM
0.241x
Magna Terra Minerals Inc
V:MTT
0.179x
Lion Industries Corporation Bhd
KLSE:4235
-0.076x
Smithson Investment Trust PLC
LSE:SSON
0.000x
Indivior PLC
LSE:INDV
-0.612x

Annual Cash Flow Conversion Efficiency for Lipidor Ab (2016–2024)

The table below shows the annual cash flow conversion efficiency of Lipidor Ab from 2016 to 2024. View current stock price of Lipidor Ab for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr7.72 Million
≈ $831.01K
Skr-16.08 Million
≈ $-1.73 Million
-2.082x -216.42%
2023-12-31 Skr-9.34 Million
≈ $-1.01 Million
Skr-16.70 Million
≈ $-1.80 Million
1.789x +109.84%
2022-12-31 Skr2.15 Million
≈ $230.94K
Skr-39.00 Million
≈ $-4.20 Million
-18.174x -5811.04%
2021-12-31 Skr43.52 Million
≈ $4.68 Million
Skr-13.38 Million
≈ $-1.44 Million
-0.307x -28.15%
2020-12-31 Skr63.66 Million
≈ $6.85 Million
Skr-15.27 Million
≈ $-1.64 Million
-0.240x +56.67%
2019-12-31 Skr26.83 Million
≈ $2.89 Million
Skr-14.85 Million
≈ $-1.60 Million
-0.554x -185.21%
2018-12-31 Skr14.45 Million
≈ $1.55 Million
Skr-2.81 Million
≈ $-301.86K
-0.194x +81.58%
2017-12-31 Skr3.48 Million
≈ $374.18K
Skr-3.66 Million
≈ $-394.30K
-1.054x +76.02%
2016-12-31 Skr833.68K
≈ $89.72K
Skr-3.66 Million
≈ $-394.30K
-4.395x --

About Lipidor Ab

ST:LIPI Sweden Drug Manufacturers - General
Market Cap
$18.82 Million
Skr174.88 Million SEK
Market Cap Rank
#25398 Global
#506 in Sweden
Share Price
Skr0.22
Change (1 day)
+0.00%
52-Week Range
Skr0.22 - Skr0.22
All Time High
Skr22.60
About

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermat… Read more